Literature DB >> 24324153

Evolutionary genomics of epidemic and nonepidemic strains of Pseudomonas aeruginosa.

Jeremy R Dettman1, Nicolas Rodrigue, Shawn D Aaron, Rees Kassen.   

Abstract

Pseudomonas aeruginosa is an opportunistic pathogen of humans and is a major cause of morbidity and mortality in patients with cystic fibrosis (CF). Prolonged infection of the respiratory tract can lead to adaptation of the pathogen to the CF lung environment. To examine the general patterns of adaptation associated with chronic infection, we obtained genome sequences from a collection of P. aeruginosa isolated from airways of patients with CF. Our analyses support a nonclonal epidemic population structure, with a background of unique, recombining genotypes, and the rare occurrence of successful epidemic clones. We present unique genome sequence evidence for the intercontinental spread of an epidemic strain shared between CF clinics in the United Kingdom and North America. Analyses of core and accessory genomes identified candidate genes and important functional pathways associated with adaptive evolution. Many genes of interest were involved in biological functions with obvious roles in this pathosystem, such as biofilm formation, antibiotic metabolism, pathogenesis, transport, reduction/oxidation, and secretion. Key factors driving the adaptive evolution of this pathogen within the host appear to be the presence of oxidative stressors and antibiotics. Regions of the accessory genome unique to the epidemic strain were enriched for genes in transporter families that efflux heavy metals and antibiotics. The epidemic strain was significantly more resistant than nonepidemic strains to three different antibiotics. Multiple lines of evidence suggest that selection imposed by the CF lung environment has a major influence on genomic evolution and the genetic characteristics of P. aeruginosa isolates causing contemporary infection.

Entities:  

Keywords:  multidrug resistance; redox balance; virulence

Mesh:

Substances:

Year:  2013        PMID: 24324153      PMCID: PMC3876195          DOI: 10.1073/pnas.1307862110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

Review 1.  Efflux-mediated antimicrobial resistance.

Authors:  Keith Poole
Journal:  J Antimicrob Chemother       Date:  2005-05-24       Impact factor: 5.790

Review 2.  Evolutionary origins of multidrug and drug-specific efflux pumps in bacteria.

Authors:  M H Saier; I T Paulsen; M K Sliwinski; S S Pao; R A Skurray; H Nikaido
Journal:  FASEB J       Date:  1998-03       Impact factor: 5.191

3.  Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients.

Authors:  Eric E Smith; Danielle G Buckley; Zaining Wu; Channakhone Saenphimmachak; Lucas R Hoffman; David A D'Argenio; Samuel I Miller; Bonnie W Ramsey; David P Speert; Samuel M Moskowitz; Jane L Burns; Rajinder Kaul; Maynard V Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-10       Impact factor: 11.205

Review 4.  Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective.

Authors:  Anders Folkesson; Lars Jelsbak; Lei Yang; Helle Krogh Johansen; Oana Ciofu; Niels Høiby; Søren Molin
Journal:  Nat Rev Microbiol       Date:  2012-11-13       Impact factor: 60.633

Review 5.  The changing microbial epidemiology in cystic fibrosis.

Authors:  John J Lipuma
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

6.  Pseudomonas aeruginosa type III-secreted toxin ExoT inhibits host-cell division by targeting cytokinesis at multiple steps.

Authors:  Sasha H Shafikhani; Joanne Engel
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-09       Impact factor: 11.205

7.  Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections.

Authors:  Eilidh Mowat; Steve Paterson; Joanne L Fothergill; Elli A Wright; Martin J Ledson; Martin J Walshaw; Michael A Brockhurst; Craig Winstanley
Journal:  Am J Respir Crit Care Med       Date:  2011-02-04       Impact factor: 21.405

Review 8.  Anaerobic physiology of Pseudomonas aeruginosa in the cystic fibrosis lung.

Authors:  Max Schobert; Dieter Jahn
Journal:  Int J Med Microbiol       Date:  2010-10-16       Impact factor: 3.473

9.  Endogenous nitric oxide protects bacteria against a wide spectrum of antibiotics.

Authors:  Ivan Gusarov; Konstantin Shatalin; Marina Starodubtseva; Evgeny Nudler
Journal:  Science       Date:  2009-09-11       Impact factor: 47.728

10.  BIGSdb: Scalable analysis of bacterial genome variation at the population level.

Authors:  Keith A Jolley; Martin C J Maiden
Journal:  BMC Bioinformatics       Date:  2010-12-10       Impact factor: 3.169

View more
  48 in total

Review 1.  Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface.

Authors:  Sankalp Malhotra; Don Hayes; Daniel J Wozniak
Journal:  Clin Microbiol Rev       Date:  2019-05-29       Impact factor: 26.132

Review 2.  Epidemiology, Biology, and Impact of Clonal Pseudomonas aeruginosa Infections in Cystic Fibrosis.

Authors:  Michael D Parkins; Ranjani Somayaji; Valerie J Waters
Journal:  Clin Microbiol Rev       Date:  2018-08-29       Impact factor: 26.132

3.  Liverpool Epidemic Strain Isolates of Pseudomonas aeruginosa Display High Levels of Antimicrobial Resistance during Both Planktonic and Biofilm Growth.

Authors:  Mara C Goodyear; Nicole E Garnier; Roger C Levesque; Cezar M Khursigara
Journal:  Microbiol Spectr       Date:  2022-06-06

4.  Rapid diversification of Pseudomonas aeruginosa in cystic fibrosis lung-like conditions.

Authors:  Alana Schick; Rees Kassen
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-01       Impact factor: 11.205

5.  Adaptation of iron homeostasis pathways by a Pseudomonas aeruginosa pyoverdine mutant in the cystic fibrosis lung.

Authors:  Angela T Nguyen; Maura J O'Neill; Annabelle M Watts; Cynthia L Robson; Iain L Lamont; Angela Wilks; Amanda G Oglesby-Sherrouse
Journal:  J Bacteriol       Date:  2014-04-11       Impact factor: 3.490

Review 6.  Genomic epidemiology of multidrug-resistant Gram-negative organisms.

Authors:  Shawn E Hawken; Evan S Snitkin
Journal:  Ann N Y Acad Sci       Date:  2018-03-31       Impact factor: 5.691

7.  The effect of loss of O-antigen ligase on phagocytic susceptibility of motile and non-motile Pseudomonas aeruginosa.

Authors:  Sally Demirdjian; Kristin Schutz; Matthew J Wargo; Joseph S Lam; Brent Berwin
Journal:  Mol Immunol       Date:  2017-10-20       Impact factor: 4.407

8.  TRPC6 channel translocation into phagosomal membrane augments phagosomal function.

Authors:  Vladimir Riazanski; Aida G Gabdoulkhakova; Lin S Boynton; Raphael R Eguchi; Ludmila V Deriy; D Kyle Hogarth; Nadège Loaëc; Nassima Oumata; Hervé Galons; Mary E Brown; Pavel Shevchenko; Alexander J Gallan; Sang Gune Yoo; Anjaparavanda P Naren; Mitchel L Villereal; Daniel W Beacham; Vytautas P Bindokas; Lutz Birnbaumer; Laurent Meijer; Deborah J Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-10       Impact factor: 11.205

Review 9.  Lipopolysaccharide modification in Gram-negative bacteria during chronic infection.

Authors:  Rita F Maldonado; Isabel Sá-Correia; Miguel A Valvano
Journal:  FEMS Microbiol Rev       Date:  2016-04-12       Impact factor: 16.408

10.  Polyclonality, Shared Strains, and Convergent Evolution in Chronic Cystic Fibrosis Staphylococcus aureus Airway Infection.

Authors:  Dustin R Long; Daniel J Wolter; Michael Lee; Mimi Precit; Kathryn McLean; Elizabeth Holmes; Kelsi Penewit; Adam Waalkes; Lucas R Hoffman; Stephen J Salipante
Journal:  Am J Respir Crit Care Med       Date:  2021-05-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.